Pfizer-BioNTech, Moderna and Johnson & Johnson Ramp Up COVID-19 Vaccines for U.S. Population, an Industrial Info Market Brief
Pfizer-BioNTech, Moderna and Johnson & Johnson Ramp Up COVID-19 Vaccines for U.S. Population, an Industrial Info Market Brief
Attachment: A
Pfizer Corporation-BioNTech, Johnson & Johnson and Moderna are fervently producing COVID-19 vaccines for the U.S. population. Pfizer-BioNTech is primarily producing the vaccine at Pfizer's facility in Kalamazoo, Michigan. Moderna and Johnson & Johnson are contracting out much of their COVID-19 vaccine manufacturing to Catalent, using its facility in Bloomington, Indiana.
As of March 23, about one in four Americans had rece
As of March 23, about one in four Americans had received at least their first COVID-19 vaccine dose.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Novo Nordisk Spends $11 Billion to Make More Weight Loss Drugs
- Industrial Manufacturing Leads Michigan to $7.5 Billion in Projects
- EU Adds New COVID-19 Manufacturing Capacity
- Global Pharma-Bio Industry Boasts More Than $87 Billion in Projects with Fu...
- Catalent Amps Up Contract Biological Manufacturing Capacity Plans to $200 m...